Get started
Author

Catarina Abreu

Observed names: Abreu, Catarina, C.D. Abreu
Observed institutions: University of Lisbon, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Instituto de Medicina Molecular João Lobo Antunes, Centro Académico de Medicina de Lisboa, Unidade Local de Saúde Santa Maria
ORCID: 0000-0003-3558-3966
Observed ORCID: 0000-0003-3558-3966
OpenAlex ID: A5111198684
Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development
2022 · Daniel Sobral, Marta Martins, et al. · Communications Biology · 59
PDF
Oncobiology and treatment of breast cancer in young women
2022 · Rakesh Kumar, Catarina Abreu, et al. · Cancer and Metastasis Reviews · 49
HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome
2021 · Mahdi Golkaram, Michael L. Salmans, et al. · npj Genomic Medicine · 41
PDF
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
2019 · André Mansinho, Arlindo R. Ferreira, et al. · International Journal of Molecular Sciences · 29
PDF
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
2023 · Inês Gomes, Catarina Abreu, et al. · Cancers · 27
PDF
Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer‐induced bone loss
2019 · Maria Rita Dionísio, André Mansinho, et al. · British Journal of Clinical Pharmacology · 26
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities
2023 · Miguel Esperança-Martins, Cecília Melo-Alvim, et al. · Cancers · 19
PDF
Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization
2023 · Carolina Peixoto, Marta B. Lopes, et al. · BMC Bioinformatics · 18
PDF
Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer
2023 · Inês Gomes, Lina M. Gallego-Paez, et al. · Cell Reports Medicine · 14
PDF
Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors
2015 · Ana Lúcia Costa, Catarina Abreu, et al. · BioMed Research International · 12
PDF
Bone Health in Metastatic Cancer
2022 · Carla Ventura, Soledad Vanesa Núñez, et al. · Seminars in Oncology Nursing · 11
The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
2016 · Arlindo Ferreira, Irina Alho, et al. · Oncotarget · 9
PDF
Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study
2022 · Manuela Fiuza, Andreia Magalhães, et al. · Revista Portuguesa de Cardiologia · 8
PDF
Exploring new pathways in endocrine-resistant breast cancer
2022 · Inês Soares de Pinho, Catarina Abreu, et al. · Exploration of Targeted Anti-tumor Therapy · 8
PDF
Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese Study
2025 · Rita Bizarro, Isabel Pazos, et al. · Cureus · 5
DNA damage targeted therapy for advanced breast cancer
2024 · Vanessa Patel, Sandra Casimiro, et al. · Exploration of Targeted Anti-tumor Therapy · 4
Large-vessel vasculitis induced by pegfilgrastim.
2021 · Ryan Costa Silva, Margarida Monteiro, et al. · PubMed · 4
Cancer Treatment-Induced Bone Loss (CTIBL)
2018 · Catarina Abreu, Maria R. Dionísio, et al. · Elsevier eBooks · 4
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response
2025 · Inês Gomes, Maria Martelo, et al. · Molecular Cancer Therapeutics · 3
Activation of PI3K/AKT/mTOR pathway in ER+ breast cancer: Analysis of paired primary and metastatic tumor samples.
2015 · Teresa R. Pacheco, Afonso C. Fernandes, et al. · Journal of Clinical Oncology · 2
CDK4/6 Inhibitors-Induced Macrocytosis Is Not Associated with Hemolysis and Does Not Impact Hemoglobin Homeostasis
2025 · Tiago Barroso, Leila Costa, et al. · Cancers · 1
PDF
195P Real-life experience of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive advanced breast cancer: A multicentric Portuguese study
2024 · R.C. Bizarro, M.I. Pazos Portela, et al. · ESMO Open · 1
PDF
Landscape of Current Targeted Therapies for Advanced Colorectal Cancer
2021 · Ana João Pissarra, Catarina Abreu, et al. · IntechOpen eBooks · 1
PDF
Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in Portugal
2026 · Nuno Tavares, Pedro Simões, et al. · Current Oncology
PDF
531P Ribociclib treatment patterns and clinical outcomes among women with HR+/HER2- advanced or metastatic breast cancer in Portugal: Final 3-year results from breast cancer lighthouse real-world study
2025 · L.I. Silva Pinto, A.L.V. Matos, et al. · Annals of Oncology
Works count: 48
Citation count: 355
H-index: 11
I10-index: 11
Year
Topic
Type